Pleiotropic effects of glucagon-like peptide-1 (GLP-1)-based therapies on vascular complications in diabetes
The FDA will continue to actively monitor for violations of federal law involving the marketing of GLP-1 products and will take appropriate enforcement action against the manufacture, distribution and sale of illegal drug products, spokesperson Emily G
GLP-1 medications provide important metabolic benefitsimproved blood sugar control, reduced cardiovascular risk, better blood pressure, and decreased inflammation
This is the single most common cause of injection pain that people overlook
If GLP-1 therapy produces meaningful weight loss and improved health markers, surgery is not necessary

For type 2 diabetes, your options include: DPP-4 inhibitors GLP-1 receptor agonists (Ozempic, Trulicity, Victoza) GLP-1/GIP receptor agonists (Mounjaro) SGLT2 inhibitors Thiazolidinediones And prescription weight-loss medications that are currently available include: Orforglipron, an oral small-molecule non-peptide GLP-1 receptor agonist ( Foundayo ) GLP-1/GIP receptor agonists ( Zepbound ) Phentermine-topiramate ( Qsymia ) Bupropion-naltrexone ( Contrave ) Your clinician, like those through Weight Watchers Med+ , can go over your available options and, if you qualify, prescribe medication and a lifestyle plan designed for your body and your goals.* Retatrutide warnings and precautions Despite the fact that retatrutide is not an approved medication, there is active marketing for medications being characterized as retatrutide. Because retatrutide is still investigational, there is no regulated manufacturing or supply chain, meaning you cannot be sure what you are actually receiving and putting in your body, says Rhodes
